Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Endocrinology / Wound care

Derm Cases · Dermatology / Endocrinology / Wound care

OSCE — yellow pretibial plaques: diagnose necrobiosis lipoidica and prevent ulceration

An 8-minute OSCE station on recognising classic pretibial necrobiosis lipoidica, diabetes association, biopsy indications, ulcer risk and stepwise medical/wound management including when to escalate.

8 minosce2 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on recognising classic pretibial necrobiosis lipoidica, diabetes association, biopsy indications, ulcer risk and stepwise medical/wound management including when to escalate.

Brief (to candidate)

A 42-year-old woman with longstanding type 1 diabetes has shiny yellow-brown pretibial plaques with telangiectasia and a violaceous rim; one plaque recently ulcerated after minor trauma. You have 8 minutes to diagnose necrobiosis lipoidica, organise metabolic assessment, and manage ulcer risk.

[3]

Candidate instructions

  1. Give the classic morphology and site of NL.
  2. State the diabetes association and other differentials of pretibial plaques/ulcers.
  3. Indicate when to biopsy and expected histology concept (necrobiosis/granulomatous degeneration).
  4. Outline treatment ladder for non-ulcerated and ulcerated NL.
  5. Counsel on trauma avoidance and red flags (including rare SCC in chronic ulcer).
[6]

Examiner checklist (mark each domain / 10)

DomainKey actions expected
Clinical diagnosisYellow-brown, waxy/shiny, atrophic pretibial plaques with telangiectasia and violaceous active rim — NL until proven otherwise[1][8]
AssociationStrong association with diabetes mellitus (type 1 classic) though NL can precede or occur without known DM — always assess glycaemic status and vascular risk[1]
Histology conceptDegeneration of dermal collagen (necrobiosis) with granulomatous inflammation; layered dermal involvement distinguishes from GA conceptually[2]
Biopsy triggersAtypical site, lack of classic morphology, rapid growth, nodularity, disproportionate pain, suspicious ulcer edge, failure of expected course — exclude infection, other granulomatous disease, malignancy
Ulcer careNL ulcers are common complication; protect from trauma, wound care, infection control; differentiate venous/arterial/neuropathic ulcers on legs[6]
TherapyPotent topical/IL corticosteroids for active rim; calcineurin inhibitors, phototherapy, systemic agents (e.g. antimalarials, fumarates, biologics in refractory) per specialist/guideline pathways; optimise diabetes control as general health measure (skin response variable)[3]
Safety-netChronic non-healing ulcer edge → consider biopsy for SCC; multidisciplinary wound/endocrine input

Model key actions

  • Recognise classic pretibial NL morphology and link to diabetes screening/optimisation.[1][8]
  • Prevent and manage ulceration with trauma avoidance and structured wound care.[6]
  • Escalate atypical or refractory disease along guideline-informed pathways.[3]

Common errors

  • Calling every pretibial rash NL without considering stasis dermatitis, GA, sarcoid, pretibial myxoedema.
  • Aggressive debridement of inflammatory NL ulcers as if purely venous without diagnosis.
  • Ignoring glycaemic assessment.
  • Missing malignant change in chronic ulcerated plaques.
  • Promising that tight HbA1c alone will reliably reverse established NL.
[1] [3] [6]
References5ShowHide
  1. [1]Lima AL, Illing T, Schliemann S, et al. Cutaneous Manifestations of Diabetes Mellitus: A Review. American Journal of Clinical Dermatology, 2017.PMID 28374407
  2. [2]Terziroli Beretta-Piccoli B, Mainetti C, Peeters MA, et al. Cutaneous Granulomatosis: a Comprehensive Review. Clinical Reviews in Allergy & Immunology, 2018.PMID 29352388
  3. [3]Erfurt-Berge C, Renner R, Peckruhn M, et al. S1-Guideline for diagnosis and therapy of necrobiosis lipoidica. Journal der Deutschen Dermatologischen Gesellschaft, 2026.PMID 41420334
  4. [6]Dissemond J, Placke JM, Moelleken M, et al. The Differential Diagnosis of Leg Ulcers. Deutsches Arzteblatt International, 2024.PMID 39115274
  5. [8]Liu MJ, Li J. Necrobiosis Lipoidica. The New England Journal of Medicine, 2024.PMID 38169491
PreviousOSCE — xeroderma pigmentosum: photoprotection, cancer vigilance, counsellingDermatology / Genetics / Oncology / Ophthalmology / Paediatrics